Cargando…

Bortezomib/cyclophosphamide/dexamethasone: Reinfection in the form of COVID-19 pneumonia : case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119606/ http://dx.doi.org/10.1007/s40278-021-95761-3

Ejemplares similares

Bortezomib/dexamethasone: Covid-19 pneumonia: case report
Publicado: (2021)

Bortezomib/dexamethasone: COVID-19 infection: case report
Publicado: (2021)

Epidural Extramedullary Plasmacytoma Successfully Treated with Surgical Excision and Bortezomib, Cyclophosphamide and Dexamethasone
por: MARTIO, ARTUR EDUARDO, et al.
Publicado: (2023)

Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis
por: Brennan, Xavier, et al.
Publicado: (2022)

Dexamethasone: COVID-19-pneumonia: case report
Publicado: (2022)

Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
por: Sauer, Sandra, et al.
Publicado: (2023)

Bortezomib/dexamethasone/oxytetracycline: Chalazia, blepharitis and lack of efficacy: case report
Publicado: (2021)

Dexamethasone: Rebound of COVID-19-pneumonia: case report
Publicado: (2021)

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
por: Crusoe, Edvan De Queiroz, et al.
Publicado: (2020)

Immunosuppressants: COVID-19 reinfection: case report
Publicado: (2021)

Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
por: Win, Hninyee, et al.
Publicado: (2020)

Methotrexate/prednisone: COVID-19 reinfection and methicillin-resistant Staphylococcus aureus pneumonia: case report
Publicado: (2021)

Dexamethasone/temozolomide: COVID-19 and COVID-19 pneumonia: 5 case reports
Publicado: (2021)

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study
por: Yimer, Habte, et al.
Publicado: (2019)

Case Report on Renal Failure Reversal in Lambda Chain Multiple Myeloma with Bortezomib and Dexamethasone
por: Patibandla, Bhanu K., et al.
Publicado: (2014)

Fibronectin glomerulopathy with monoclonal gammopathy responding to bortezomib plus dexamethasone: a case report
por: Li, Xiaoli, et al.
Publicado: (2022)

Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Severe Acute Hepatitis B in HBV-Vaccinated Partner of a Patient with Multiple Myeloma Treated with Cyclophosphamide, Bortezomib, and Dexamethasone and Autologous Stem Cell Transplant
por: Almaghrabi, Majed M., et al.
Publicado: (2017)

Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report
por: Chan, Steven M, et al.
Publicado: (2009)

Reduced Weekly Subcutaneous Doses of Bortezomib in Combination with Cyclophosphamide and Dexamethasone for Newly Diagnosed Multiple Myeloma
por: Ashrafi, Farzaneh, et al.
Publicado: (2020)

Multiple drugs: Covid-19 reinfection: 2 case reports
Publicado: (2021)

Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
por: O’Connor-Byrne, N., et al.
Publicado: (2019)

Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Deferasirox: COVID-19 infection and asymptomatic COVID-19 reinfection: case report
Publicado: (2021)

A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
por: Kuang, Chaoyuan, et al.
Publicado: (2020)

Varicella Reinfection with Unilateral Varicella Pneumonia
por: Ariyasu, Ryo, et al.
Publicado: (2016)

Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
por: Andersen, Kristian T., et al.
Publicado: (2020)

Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib
por: Kastritis, E, et al.
Publicado: (2017)

Dexamethasone: Pneumocystis jirovecii pneumonia: case report
Publicado: (2022)

Dexamethasone: Klebsiella pneumoniae infection: case report
Publicado: (2022)

Cyclophosphamide/rituximab: COVID-19 infection: case report
Publicado: (2021)

Cyclophosphamide/methylprednisolone: COVID-19 infection: case report
Publicado: (2021)

The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma
por: Hashimoto, Shigeo, et al.
Publicado: (2016)

The first case of documented Covid-19 reinfection in Israel
por: Nachmias, Vered, et al.
Publicado: (2020)

Multiple drugs: COVID-19 reinfection, COVID-19 reactivation and differentiation syndrome: case report
Publicado: (2021)

Recurrent COVID-19 in Hemodialysis: A Case Report of 2 Possible Reinfections
por: Krishna, Vinay Narasimha, et al.
Publicado: (2021)

COVID-19 Reinfection in a Patient with Hodgkin Lymphoma: a Case Report
por: Fakharian, Atefeh, et al.
Publicado: (2021)

COVID-19 Reinfection in a Young Medical Doctor: A Case Report
por: Gaire, Dhruba, et al.
Publicado: (2021)

Possible COVID-19 reinfection case in Duhok City, Kurdistan: A case report
por: Hussein, Nawfal R., et al.
Publicado: (2021)

Dexamethasone misuse: Delayed viral clearance leading to severe COVID-19 pneumonia: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ec6qh9fel83miu5t9m779go2c